BiolineRx

Indonesia
Sumbul, North Sumatra, Indonesia, 91450

Company profile

BiolineRx company profile

BioLineRx is a clinical-stage, publicly traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel. The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.

Business identity

Contact email
[email protected]
Phone number
+972 2-548-9100
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2003-01-01, Year

Headquarters

Postal code
91450
Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
18
Total equity funding
$236.7M
Last funding
Post IPO Equity / $10M / 2025-01-06
Last equity funding
Post IPO Equity / $10M
Investors
11
Lead investors
6
Founders
1
Articles
136
Exited on
2007-02-07

Founders and investors

Founders

Morris Laster

Lead investors

Biotechnology Value FundGiza Venture CapitalHighbridge Capital ManagementKreos CapitalPitango VCTeva Pharmaceuticals

Investors

BlackRockNovartisOrbiMedPitango VCTeva Pharmaceuticals